These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6410148)

  • 21. Direct agglutination test in the detection of anti-Trypanosoma cruzi antibodies in mice.
    Schmunis GA; Szarfman A; Vattuone N
    J Parasitol; 1972 Oct; 58(5):1006-7. PubMed ID: 4627886
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterogeneity of the humoral immune response in humans infected with Trypanosoma cruzi].
    Vottero-Cima E; Faillaci MG; Rubiolo ER; Gea S; Pistoresi C
    Medicina (B Aires); 1980; 40 Suppl 1():121-6. PubMed ID: 6779075
    [No Abstract]   [Full Text] [Related]  

  • 23. Trypanosoma cruzi antibodies in mice infected with different strains of T.cruzi.
    Peralta JM; Filardi L; Loures MA; Torres ST
    J Parasitol; 1980 Apr; 66(2):342-4. PubMed ID: 6771373
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance.
    Garcia IE; Lima MR; Marinho CR; Kipnis TL; Furtado GC; Alvarez JM
    J Parasitol; 1997 Apr; 83(2):230-3. PubMed ID: 9105302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serological studies in patients with chronic Chagas' disease].
    Carbonetto CH; Hajos SE; Margni RA; Esteva M; Cristopoulos C
    Medicina (B Aires); 1983; 43(2):131-6. PubMed ID: 6420641
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of extracts rich in immune RNA on some immunopathological parameters of rats infected with Trypanosoma cruzi].
    Revelli S; Moreno H; Berra H; Velenti JL; Nocito A; Amerio N; Morini JC
    Bol Chil Parasitol; 1985; 40(3-4):51-7. PubMed ID: 3939407
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic infection in mice with Trypanosoma cruzi.
    Bijovsky AT; Elizari MV; Muller LA; Katzin VJ; González Cappa SM
    Rev Inst Med Trop Sao Paulo; 1983; 25(5):207-14. PubMed ID: 6424217
    [No Abstract]   [Full Text] [Related]  

  • 29. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of acute infection by Trypanosoma cruzi upon the response of mice to sheep erythrocytes.
    Schmuñis GA; Szarfman A; Pesce UJ; González-Cappa SM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):323-31. PubMed ID: 416482
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of antibodies against the glycolipid fraction of Trypanosoma cruzi in infected mice.
    Kaneda Y; Tachibana H; Goutsu T
    J Parasitol; 1987 Jun; 73(3):658-61. PubMed ID: 3110395
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of mammalian host cell infection by insect-derived, metacyclic forms of Trypanosoma cruzi in the presence of human or rabbit anti-T. cruzi antibodies.
    Wirth JJ; Kierszenbaum F
    Int J Parasitol; 1987 Feb; 17(3):841-5. PubMed ID: 3106253
    [No Abstract]   [Full Text] [Related]  

  • 34. [Possibility of incorporation of the host proteins by Trypanosoma cruzi (experimental research)].
    Andrade SG
    Rev Inst Med Trop Sao Paulo; 1978; 20(5):279-84. PubMed ID: 103173
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection.
    Camargo ME; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1974; 16(4):200-2. PubMed ID: 4218652
    [No Abstract]   [Full Text] [Related]  

  • 36. Trypanosoma cruzi tubulin eliminated in the urine of the infected host.
    Bertot GM; Corral RS; Fresno M; Rodríguez C; Katzin AM; Grinstein S
    J Parasitol; 1998 Jun; 84(3):608-14. PubMed ID: 9645865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS
    Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of antigens of culture forms of Trypanosoma cruzi and Trypanosoma rangeli recognized by sera from patients with chronic Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1984 Oct; 70(5):822-4. PubMed ID: 6439848
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
    Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
    J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.